Urticarial vasculitis: Difference between revisions

Revision as of 05:26, 16 February 2025

Urticarial Vasculitis

Urticarial vasculitis is a rare form of vasculitis characterized by the presence of urticarial lesions that are associated with histological evidence of leukocytoclastic vasculitis. Unlike typical urticaria, the lesions in urticarial vasculitis are often painful, last longer than 24 hours, and may leave residual hyperpigmentation.

Pathophysiology

Urticarial vasculitis is associated with the activation of the complement system, particularly the classical pathway. The complement pathway is a part of the immune system that enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells. In urticarial vasculitis, the activation of the complement system leads to inflammation and damage to the small blood vessels in the skin.

Clinical Features

Patients with urticarial vasculitis typically present with:

Urticarial lesions that are painful or burning rather than itchy.
Lesions that persist for more than 24 hours.
Possible systemic symptoms such as fever, arthralgia, and abdominal pain.
Residual hyperpigmentation or purpura after the lesions resolve.

Diagnosis

The diagnosis of urticarial vasculitis is confirmed by a skin biopsy showing leukocytoclastic vasculitis. Laboratory tests may reveal low levels of complement components, such as C3 and C4, indicating complement consumption.

Treatment

Treatment of urticarial vasculitis depends on the severity of the disease and the presence of systemic involvement. Options include:

Antihistamines for symptomatic relief.
Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation.
Corticosteroids for more severe cases.
Immunosuppressive agents such as azathioprine or cyclophosphamide for refractory cases.

Prognosis

The prognosis of urticarial vasculitis varies. Some patients experience a self-limited course, while others may have chronic or recurrent disease. The presence of systemic involvement can affect the overall prognosis.

Related Pages

@@ Line 1: / Line 1: @@
-{{Short description|A rare form of vasculitis affecting the skin}}
+{{DISPLAYTITLE:Urticarial Vasculitis}}
-{{Use dmy dates|date=October 2023}}
-'''Urticarial vasculitis''' is a rare form of [[vasculitis]] characterized by inflammation of the small blood vessels in the skin, leading to a persistent [[urticaria|urticarial rash]]. Unlike typical urticaria, the lesions in urticarial vasculitis are often painful and can last for more than 24 hours. This condition can be associated with systemic symptoms and may be indicative of an underlying systemic disease.
+== Urticarial Vasculitis ==
+[[File:Complement_pathway.svg|thumb|right|Diagram of the complement pathway, which is involved in urticarial vasculitis.]]
-==Pathophysiology==
+'''Urticarial vasculitis''' is a rare form of [[vasculitis]] characterized by the presence of urticarial lesions that are associated with histological evidence of [[leukocytoclastic vasculitis]]. Unlike typical [[urticaria]], the lesions in urticarial vasculitis are often painful, last longer than 24 hours, and may leave residual [[hyperpigmentation]].
-Urticarial vasculitis is believed to be an immune complex-mediated disorder. The [[complement system]], particularly the [[complement pathway|classical complement pathway]], plays a significant role in its pathogenesis. The activation of this pathway leads to the deposition of immune complexes in the small blood vessels, causing inflammation and damage.
-[[File:Complement pathway.svg|thumb|right|Diagram of the complement pathway, which is involved in the pathogenesis of urticarial vasculitis.]]
+== Pathophysiology ==
+Urticarial vasculitis is associated with the activation of the [[complement system]], particularly the classical pathway. The complement pathway is a part of the [[immune system]] that enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells. In urticarial vasculitis, the activation of the complement system leads to inflammation and damage to the small blood vessels in the skin.
-==Clinical Features==
+== Clinical Features ==
-The primary symptom of urticarial vasculitis is a rash that resembles urticaria but is distinguished by its persistence and associated pain. The lesions are often red, raised, and may be accompanied by a burning sensation. Systemic symptoms can include fever, joint pain, and abdominal pain. In some cases, urticarial vasculitis can be associated with [[systemic lupus erythematosus]], [[Sjogren's syndrome]], or other autoimmune disorders.
+Patients with urticarial vasculitis typically present with:
+* Urticarial lesions that are painful or burning rather than itchy.
+* Lesions that persist for more than 24 hours.
+* Possible systemic symptoms such as fever, arthralgia, and abdominal pain.
+* Residual hyperpigmentation or purpura after the lesions resolve.
-==Diagnosis==
+== Diagnosis ==
-Diagnosis of urticarial vasculitis is based on clinical evaluation and histopathological examination of a skin biopsy. The biopsy typically shows leukocytoclastic vasculitis with evidence of immune complex deposition. Laboratory tests may reveal low levels of complement components, particularly C3 and C4, supporting the diagnosis.
+The diagnosis of urticarial vasculitis is confirmed by a skin biopsy showing leukocytoclastic vasculitis. Laboratory tests may reveal low levels of complement components, such as C3 and C4, indicating complement consumption.
-==Treatment==
+== Treatment ==
-Treatment of urticarial vasculitis depends on the severity of the symptoms and the presence of any underlying systemic disease. Antihistamines may provide symptomatic relief for mild cases. More severe cases may require systemic corticosteroids or immunosuppressive agents such as [[azathioprine]] or [[cyclophosphamide]].
+Treatment of urticarial vasculitis depends on the severity of the disease and the presence of systemic involvement. Options include:
+* [[Antihistamines]] for symptomatic relief.
+* [[Nonsteroidal anti-inflammatory drugs]] (NSAIDs) for pain and inflammation.
+* [[Corticosteroids]] for more severe cases.
+* Immunosuppressive agents such as [[azathioprine]] or [[cyclophosphamide]] for refractory cases.
-==Prognosis==
+== Prognosis ==
-The prognosis of urticarial vasculitis varies depending on the underlying cause and the severity of the disease. In cases associated with systemic disease, the prognosis is more guarded and requires careful management of the underlying condition.
+The prognosis of urticarial vasculitis varies. Some patients experience a self-limited course, while others may have chronic or recurrent disease. The presence of systemic involvement can affect the overall prognosis.
-==Related pages==
+== Related Pages ==
 * [[Vasculitis]]
 * [[Urticaria]]
-* [[Systemic lupus erythematosus]]
+* [[Complement system]]
-* [[Sjogren's syndrome]]
+* [[Immune system]]
-==References==
-* {{cite book |last=James |first=W.D. |title=Andrews' Diseases of the Skin: Clinical Dermatology |edition=13th |publisher=Elsevier |year=2020 |isbn=978-0-323-54753-6}}
+[[Category:Dermatology]]
 [[Category:Vasculitis]]
-[[Category:Dermatology]]